Study guide

Anemia And RBC Disorders

ASCP MLS Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Orientation To ASCP MLS Certification

Credential Purpose And Role ASCP BOC And Eligibility At A High Level MLS Versus MLS(ASCPi) Wording Application Fee And Transcript Result Basics CAT Exam Model Overview Study Plan From Content Guideline

2 Exam Format, CAT Scoring, And Score details

100 Questions And 2h30m Computer Adaptive Testing One-Best-Answer Multiple Choice Theoretical Versus Procedural Questions Scaled Score 100-999, Minimum 400 Score Notification Timing And Transcript Dependency

3 Blood Banking

Products And Components Blood Group Systems And Immunology Serologic And Molecular Testing Compatibility Testing And Transfusion Practice Physiology And Pathophysiology High-Yield Study Strategy

4 Chemistry

Carbohydrates, Lipids, Proteins, And Nitrogen Compounds Enzymes And Heme Derivatives Acid-Base, Blood Gases, And Electrolytes Endocrinology, Vitamins, And Nutrition Therapeutic Drug Monitoring And Toxicology Calculations And Correlation

5 Hematology And Hemostasis

Normal Hematopoiesis And Cell Morphology Anemia And RBC Disorders Leukocyte Disorders And Disease States Platelet And Coagulation Physiology Hemostasis Testing Smear, Analyzer, And Result Correlation

6 Microbiology

Preanalytic Specimen Handling Bacteriology Analytic Procedures Susceptibility And Organism Identification Logic Mycobacteriology, Virology, Parasitology, And Mycology Postanalytic Reporting Safety And Contamination Awareness

7 Urinalysis And Other Body Fluids

Physical And Chemical Urinalysis Microscopic Sediment Renal Physiology And Disease States CSF And Serous Fluids Body Fluid Cell Counts And Crystals Correlation And Preanalytic Issues

8 Immunology

Principles Of Immune Response Immune-System Diseases Infectious Disease Serology Transplantation And Compatibility Concepts Serologic Procedures And Test Methodology Interpretation Pitfalls

9 Laboratory Operations

Quality Assessment And Troubleshooting Safety Laboratory Mathematics Manual And Automated Methodology Instrumentation And Validation Management And Education Principles

10 Integrated Case Reasoning And Calculations

Correlating Patient Results To Disease States Applying Knowledge To New Facts Calculations And Units Procedural Decision-Making QA/QC In Case Questions Avoiding Memorization-Only Study

11 Practice Strategy And Remediation

Content Percentage Allocation CAT-Aware Practice Mindset Reviewing Misses By Domain Using The Official Guideline Before Third-Party Materials Transcript And Result Timing In Planning Final Remediation Cycles

12 Final Review And Exam-Day Readiness

Final-Week Schedule Timing And Pacing Score Expectations Result And Credential Next Steps Digital Badge And Documentation Post-Exam Actions Without Promises

Anemia And RBC Disorders

Key Takeaways Explain This Topic AI

Classify anemia first by MCV: microcytic (<80 fL), normocytic (80-100 fL), macrocytic (>100 fL).

Iron studies separate iron deficiency (low ferritin, high TIBC) from anemia of chronic disease (high/normal ferritin, low TIBC).

RDW is the earliest index to rise in iron deficiency and helps distinguish it from thalassemia trait.

Hemolytic anemias share high reticulocytes, high LDH, high indirect bilirubin, and low haptoglobin.

Last updated: November 2026

Classifying Anemia By MCV

Anemia is a reduction in hemoglobin, hematocrit, or red cell mass below the reference interval. The MLS exam expects the MCV-based morphologic classification as the first triage step:

  • MCV Classification Classic causes
  • < 80 fL Microcytic Iron deficiency, thalassemia, anemia of chronic disease, sideroblastic
  • 80-100 fL Normocytic Acute blood loss, hemolysis, renal disease, early chronic disease
  • > 100 fL Macrocytic B12/folate deficiency (megaloblastic), liver disease, alcohol, reticulocytosis

MCV = (Hct x 10) / RBC. MCH = (Hgb x 10) / RBC. MCHC = (Hgb x 100) / Hct. Be ready to calculate any of these from a given CBC. A worked index example: with Hgb 12 g/dL, Hct 36%, and RBC 4.0 x10^12/L, MCV = (36 x 10)/4.0 = 90 fL, MCH = (12 x 10)/4.0 = 30 pg, and MCHC = (12 x 100)/36 = 33.3 g/dL - all normal, a normocytic normochromic picture. Memorize the units that go with each index (fL, pg, g/dL) because the exam will list distractor answers with the wrong magnitude.

Beyond MCV, the reticulocyte count is the second triage axis. A high reticulocyte response in an anemic patient says the marrow is working and the problem is loss or destruction (hemorrhage or hemolysis). A low or inappropriately normal reticulocyte count says the marrow is the problem (deficiency, aplasia, infiltration). The corrected reticulocyte count = reticulocyte% x (patient Hct / 45) adjusts for the degree of anemia, and the reticulocyte production index further corrects for premature release of shift reticulocytes. Pairing MCV with the reticulocyte response sorts most anemia stems before you ever read the special tests.

Microcytic Anemias And Iron Studies

The most testable distinction is iron deficiency anemia (IDA) versus anemia of chronic disease (ACD) versus thalassemia trait :

  • Test Iron deficiency Chronic disease Thalassemia trait
  • Serum iron Low Low Normal
  • TIBC High Low Normal
  • Ferritin Low High/normal Normal
  • RDW High Normal Normal
  • RBC count Low Low Normal/high

A classic exam discriminator: thalassemia trait shows a normal or elevated RBC count with low MCV (the Mentzer index, MCV/RBC, is < 13), whereas IDA shows a low RBC count and Mentzer index > 13. RDW rises early and high in IDA but stays normal in thalassemia trait.

Iron deficiency progresses in stages, and the exam may test the order in which tests turn abnormal: ferritin falls first (storage iron depletes), then serum iron drops and TIBC rises, then microcytosis and hypochromia appear, and the RDW widens as the population becomes heterogeneous. Ferritin is the single most useful test for iron stores but is also an acute-phase reactant, so in an inflamed patient a normal-appearing ferritin can mask true deficiency.

Beta-thalassemia minor classically shows an elevated hemoglobin A2 (>3.5%) on electrophoresis, the confirmatory test, whereas alpha-thalassemia trait has a normal A2 and is diagnosed by exclusion or DNA analysis. Sideroblastic anemia is a third microcytic cause: iron is present but cannot be incorporated into heme, producing ring sideroblasts (iron-laden mitochondria around the nucleus) on a Prussian blue marrow stain, with high serum iron and high ferritin - the opposite iron pattern from IDA.

Macrocytic / Megaloblastic Anemias

Megaloblastic anemia results from impaired DNA synthesis, usually vitamin B12 (cobalamin) or folate deficiency . Hallmarks: MCV often > 110 fL, hypersegmented neutrophils (>5 lobes), oval macrocytes, and pancytopenia in severe cases. B12 deficiency adds neurologic signs (folate does not). Pernicious anemia is B12 deficiency from loss of intrinsic factor; the Schilling test (historical) and intrinsic-factor antibodies confirm it.

Hemolytic Anemias

All hemolytic anemias share a laboratory signature: increased reticulocytes, increased LDH, increased indirect (unconjugated) bilirubin, and decreased haptoglobin . Distinguish by morphology and special tests:

Hereditary spherocytosis: spherocytes, increased MCHC, positive osmotic fragility, negative DAT.

G6PD deficiency: bite cells and Heinz bodies after oxidant stress; X-linked.

Sickle cell anemia: drepanocytes, target cells; confirmed by hemoglobin electrophoresis showing HbS (and screened by solubility test).

Autoimmune hemolytic anemia: spherocytes with a positive direct antiglobulin test (DAT/Coombs) - the feature that separates it from hereditary spherocytosis.

Microangiopathic (TTP, DIC, HUS): schistocytes (helmet cells, fragments).

Paroxysmal nocturnal hemoglobinuria (PNH): complement-mediated intravascular hemolysis from loss of CD55/CD59; flow cytometry confirms.

A second useful split is intravascular versus extravascular hemolysis. Intravascular destruction (PNH, transfusion reactions, microangiopathy, severe G6PD crisis) releases free hemoglobin into plasma, producing hemoglobinemia, hemoglobinuria, and hemosiderinuria and a sharply low haptoglobin. Extravascular destruction (hereditary spherocytosis, warm autoimmune hemolysis) removes cells in the spleen and liver, producing splenomegaly and indirect hyperbilirubinemia without gross hemoglobinuria.

The exam often hides the answer in this distinction - dark urine and a plasma free-hemoglobin clue point intravascular, while splenomegaly and spherocytes point extravascular.

Worked Example

A patient has Hgb 9 g/dL, MCV 72 fL, ferritin 6 ng/mL, TIBC elevated, and RDW 18%. Low ferritin is the most specific marker of depleted iron stores, so this is iron deficiency anemia , not chronic disease (which would show high ferritin) or thalassemia (normal RDW, normal RBC count).

Common Traps

Calling every microcytic anemia iron deficiency - check ferritin and RBC count to exclude thalassemia.

Forgetting that a high reticulocyte count can push MCV into the macrocytic range without B12/folate deficiency.

Confusing DAT-positive (autoimmune) with DAT-negative (hereditary) spherocytosis.